Company / Gross Profit per Share
TENAX THERAPEUTICS, INC. Gross Profit per Share History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
-$0.00
FY2016
5-year range
-$0.00 / $0.03
FY2012-FY2016
Trend
+0.9%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share returned to growth in FY2016 after 2 years of decline, reaching $-0.00.
Based on SEC 10-K filings.
-0.00 in FY2016.
Declined from $0.03 to $-0.00 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, gross profit per share increased 0.9% year-over-year.
- Peak gross profit per share was recorded in FY2013.
- Lowest gross profit per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2016 | -$0.00 | +0.9% |
| FY2015 | -$0.00 | -114.5% |
| FY2014 | $0.03 | -23.3% |
| FY2013 | $0.03 | +659.5% |
| FY2012 | $0.00 | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026